Mirae Asset Global ETFs Holdings
CMPX icon

Mirae Asset Global ETFs Holdings’s Compass Therapeutics CMPX Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$180K Buy
82,459
+8,375
+11% +$24.7K ﹤0.01% 2537
2026
Q1 		$389K Buy
74,084
+4,508
+6% +$26K ﹤0.01% 2014
2025
Q4 		$374K Buy
69,576
+19,726
+40% +$91.1K ﹤0.01% 2034
2025
Q3 		$176K Sell
49,850
-314
-0.6% -$992 ﹤0.01% 2390
2025
Q2 		$130K Sell
50,164
-10,876
-18% -$22.4K ﹤0.01% 2473
2025
Q1 		$116K Buy
61,040
+2,574
+4% +$6.84K ﹤0.01% 2564
2024
Q4 		$84.8K Buy
58,466
+2,508
+4% +$4.17K ﹤0.01% 2769
2024
Q3 		$103K Buy
55,958
+10,402
+23% +$13K ﹤0.01% 2699
2024
Q2 		$45.6K Buy
+45,556
New +$66.5K ﹤0.01% 2809

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's CMPX Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Compass Therapeutics (CMPX) stake by 11% in Q2 2026, buying an estimated $24.7K and bringing the position to 82,459 shares worth $180K. The position accounts for ﹤0.01% of the portfolio, ranked #2537.

Mirae Asset Global ETFs Holdings first reported a position in CMPX in Q2 2024 and has held it in 9 quarters since. The position peaked at $389K in Q1 2026. 215 funds tracked by Wall St. Rank hold CMPX as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 82,459 shares of Compass Therapeutics worth $180K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 8,375 Compass Therapeutics shares in Q2 2026, an estimated $24.7K.
  • Compass Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2537 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Compass Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global ETFs Holdings's Compass Therapeutics position peaked at $389K in Q1 2026.
  • 215 funds tracked by Wall St. Rank held Compass Therapeutics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.